Get the app
US › Healthcare

Si-Bone Inc (SIBN)

US · Healthcare · Medical Devices

$24.24-0.12%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$55.7M
Revenue YoY
+14.5%
Net profit
$-3.6M
EPS
$-0.08
EPS estimate
$-0.13
Net margin
-6.5%

EPS came in at -0.08 against a street estimate of -0.13 — a beat of 38.5%.

Key statistics

Market cap
$906.2M
Forward P/E
0.0
P/B
5.22
Book value
$4.08
EPS (TTM)
$-0.32
52-week high
$22.95
52-week low
$11.48
50-day MA
$19.41
200-day MA
$16.40
Beta
0.62

Analyst view

Analysts rate Si-Bone Inc a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $25.44.

Shareholding

Insiders
3.25%
Institutions
109.54%

Largest institutional holders

FundStake
First Light Asset Management, LLC18.14%
BlackRock Inc8.20%
Cadian Capital Management LP7.47%
American Century Companies Inc5.60%
Brown Advisory Holdings Inc4.63%
Granahan Investment Management Inc..4.31%
Vanguard Capital Management, LLC4.10%
Arnhold & S. Bleichroeder Advisers, LLC3.43%

Recent filings & reports

DocumentDate
Quarterly report · Q3 2026
HEADLINE NUMBERS • Third-quarter 2026 revenue was $55,704,000, up from $48,656,000 in the third quarter of 2025. • Nine-month 2026 revenue was $164,
2026-11-03
Results announced · Q4 2026
HEADLINE NUMBERS • Third-quarter worldwide revenue was $55.7 million, up 14.5% from $48.7 million. • U.S. revenue was $52.8 million, up 13.9%; U.S.
2026-11-02
Material agreement · Q3 2026
SI-BONE, INC. - FORM 8-K SUMMARY RISKS & NEGATIVES • Product Recall Initiated: Company voluntarily recalled 98 iFuse TORQ implants on August 21, 202
2026-09-11
Quarterly report · Q2 2026
SI-BONE, INC. – FORM 10-Q SUMMARY (JUNE 30, 2026) HEADLINE NUMBERS • Q2 2026 Revenue: $56.0 million (up 15% vs Q2 2025: $48.6 million) • Six-Month 2
2026-08-04
Results announced · Q3 2026
SI-BONE, INC. Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Worldwide revenue: $56.0 million, up 15.2% year-over-year • U.S. revenue: $53.2 million, u
2026-08-03
Material agreement · Q2 2026
SI-BONE, INC. (SIBN) - FORM 8-K SUMMARY HEADLINE NUMBERS • Company has 44,243,715 shares of common stock outstanding as of April 6, 2026 • 38,905,03
2026-06-08
Quarterly report · Q1 2026
SI-BONE, INC. - Q1 2026 SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Q1 2026 Revenue: $52.6 million, up 11.2% from $47.3 million in Q1 2025
2026-05-11
Results announced · Q2 2026
SI-BONE, INC. Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Worldwide revenue: $52.6 million, up 11.2% year-over-year • U.S. revenue: $49.3 million, u
2026-05-11

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Si-Bone Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.